MedTrace Logo

Providing Peer Mother Support Through Cell Phone and Group Meetings to Increase Exclusive Breastfeeding in Kenya

NCT01385410 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 823

Last updated 2013-10-25

No results posted yet for this study

Summary

This behavioural support intervention trial will investigate the potential to increase exclusive breastfeeding rates in an urban Kenyan community through peer mother support delivered either by cell phone or through group meetings. It will follow a cohort of more than 800 women attending antenatal care at a large public hospital, and compare indicators of breastfeeding and infant and maternal health between groups receiving one or other type of peer mother support. The main part of the study will test the primary hypothesis that peer group and cell phone based support can both increase rates of EBF at 3 months by 20% relative to a control group.

Conditions

  • Breastfeeding

Interventions

BEHAVIORAL

Peer mother support for continued exclusive breastfeeding

Peer counselling on breastfeeding beginning in third trimester and continuing until 3 months postpartum

Sponsors & Collaborators

  • Egerton University

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • Global Alliance for Improved Nutrition

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • University of Toronto

    lead OTHER

Principal Investigators

  • Daniel Sellen, PhD · University of Toronto

  • Elizabeth Kamau-Mbuthia, PhD · Egerton University

  • Samwel Mbugua, MSc · Egerton University

  • Aimee Webb Girard · Emory University

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-10-31
Completion
2013-01-31

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01385410 on ClinicalTrials.gov